PubHealth.info® (An Information Portal on Public Health Issues / Topics, Presented in Collaboration with PakMed Biomedical Solutions)

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]


Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

Here you can find more than 42,000 article titles on "Contraception (Birth Control) and Family Planning" , along with their abstracts and bibliographic information (one of the world's largest collections of article titles on this topic), mentioned in various lists that are sorted/arranged according to the years of publication. You can view the bibliographic details and abstracts of these articles, by clicking the title of your required article. To view other lists of articles in the same category "Contraception (Birth Control) and Family Planning", please visit "Category Lists Homepage" or select a list from the following dropdown list of article titles.

 

List 15: Articles 7001-7500 (500 Articles)

To view other lists in the same category, please VISIT LISTS HOME PAGE or select a list from the above dropdown list of article titles
  1. Potential for increased involvement of the commercial sector in family planning service delivery in the Philippines: assessment and initial strategies.
  2. Potential molecular mechanisms for the contraceptive control of implantation.
  3. The potential of pharmacists to promote family planning in Romania. A summary.
  4. Practitioners research their own practice: collaborative research in family planning.
  5. The prediction of accurate contraceptive use from attitudes and knowledge.
  6. Pregnancy terminations after oral contraception scare [letter]
  7. Present status of hormonal contraception (COCs)
  8. President Jiang Zemin on China's population and family planning.
  9. Prevalence and continuation of injectable contraceptives: evidence from extension project areas of ICDDR,B.
  10. Private physicians' provision of contraceptive services.
  11. Problems and prospects of integrating family planning with maternal and child health, with special emphasis on adolescents.
  12. Productivity and costs for family planning service delivery in Bangladesh: the government program. Main report.
  13. Productivity and costs for family planning service delivery in Bangladesh: the government program. Technical report.
  14. Productivity and costs for family planning service delivery in Bangladesh: the NGO program. Main report.
  15. Productivity and costs for family planning service delivery in Bangladesh: the NGO program. Technical report.
  16. Profile of the women using a family planning service. [Perfil de las usuarias del servicio de planificacion familiar.]
  17. Progestagen-only oral contraceptives. [Pildoras anticonceptivas de solo progestagenos.]
  18. Progestogen-only oral contraceptives and risk of breast cancer in New Zealand.
  19. Program profile: the Indonesian national family planning and family development movements. 2nd ed.
  20. Prolonged interpregnancy interval: a marker for non use of contraception and unplanned pregnancy.
  21. Promoting contraceptive choices in the Indian programme: women's perspectives.
  22. Promoting family planning through mass media in Nigeria: campaigns using public service announcements and a national logo.
  23. Promoting reproductive health in Uganda: evaluation of a national IEC program: the Uganda Family Planning Promotion Project and the Delivery of Improved Services for Health project.
  24. Promotion of family planning by the IMA: a study in Uttar Pradesh.
  25. A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives.
  26. A prospective study of adverse pregnancy outcomes among planned and unplanned pregnancies in natural family planning users.
  27. Prospective study of oral contraceptives and hypertension among women in the United States.
  28. Protecting the mother's and child's health. Indonesia. Moslems and Islamic organizations participate in the family planning movement.
  29. A protocol for "nurse only" family planning clinics.
  30. Provider-client relations in family planning clinics in Egypt [abstract]
  31. Provision of a district abortion service by a community family planning department.
  32. Provision of emergency contraception by nurses: a way forward to increased access.
  33. PSI spearheads nationwide family planning partnership in Guinea.
  34. Psychosocial conventionality, health orientation, and contraceptive use in adolescence.
  35. Public funding for contraceptive, sterilization and abortion services, 1994.
  36. Public policy issues relating to women's health: family planning, Medicaid, Medicare, and managed care [editorial]
  37. A publicity campaign for emergency contraception [letter]
  38. Punjab. Follow-up of recommendations of the Workshops on Village Based Family Planning Workers Quality Improvement.
  39. Quality of care and service: some notes from the Indonesian family planning and family development movements.
  40. Quality of family welfare services in increasing the acceptance and continuation of contraception: the case of India.
  41. The quality of Jamaica public sector and NGO family planning services: perspectives of providers and clients. Final report.
  42. Raised circulating levels of interleukin-6 in women with an intrauterine contraceptive device.
  43. A rapid assessment procedure to assess accessibility to and utilization of family planning and maternal and child health services at the local level.
  44. Re-examination of the role of governments, non-governmental organizations and the private sector in family planning.
  45. Readings on men from Family Planning Perspectives 1987-1995.
  46. Rebuilding confidence in oral contraceptives: a new imperative in family planning.
  47. Recent oral contraceptive use and risk of breast cancer (United States)
  48. Recent oral contraceptive use patterns in four European countries: evidence for selective prescribing of oral contraceptives containing third-generation progestogens.
  49. Recent studies confirm the safety of oral contraceptives with respect to stroke.
  50. Reconsidering the rationale, scope, and quality of family planning programs.
  51. Reduced risk of ovarian cancer in women with a tubal ligation or hysterectomy. The World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives.
  52. Referral compliance of Chlamydia positive patients from a family planning clinic.
  53. Regional variations in female autonomy and fertility and contraception in India.
  54. Regional variations in female autonomy and fertility and contraception in India.
  55. Reintroducing DMPA to the Philippine family planning program: a longitudinal study of continuing users and drop-outs, Philippines. Final report. Family Planning Operations Research and Training (FPORT) Program.
  56. The relative influence of husbands and wives on the choice and use of oral contraception, a diaphragm, and condoms.
  57. Reliability of data from proxy respondents in an international case-control study of cardiovascular disease and oral contraceptives.
  58. Renewed commitment. Reaffirmed collaboration. UNFPA and JOICFP strengthen and expand collaboration in field of population and reproductive health / family planning.
  59. Repeat fertility and contraceptive implant use among Medicaid recipients in Colorado.
  60. Report calls for new revolution in contraceptive technology.
  61. Report from the meeting on Women's Health, Human Rights and Family Planning Programs in Mexico and Peru, May 13, 1996.
  62. Report of Regional Workshop on Emergency Contraception, December 3-5, 1996, the Taj Mahal Hotel, Lucknow, India.
  63. Report of the Survey of Knowledge, Attitude and Family Planning Practice in the Southern Region of Thailand, 1994.
  64. Reproductive attitudes and family planning among the aboriginal peoples of Alaska, Kamchatka, and Chukotka: the results of comparative research.
  65. Reproductive decision-making and determinants of contraceptive use in HIV-infected women.
  66. Reproductive health and family planning in Bosnia and Herzegovina. Results from the first year of a post-war programme.
  67. Reproductive health aspects of contraceptive methods.
  68. Reproductive tract infections: the forgotten and neglected component of family planning services.
  69. Research confirms LAM's effectiveness. Contraceptive update.
  70. Research on new methods of emergency contraception.
  71. The results of a multipractice collaborative project on the use of postcoital contraception.
  72. The rhetoric of reproduction and the reconfiguration of womanhood in the French birth control movement, 1890-1920.
  73. RI sends family planning consultants to Asia and Africa.
  74. Risk for ovulation in women taking a low-dose oral contraceptive (Microgynon) when receiving antibacterial treatment with a fluoroquinolone (ofloxacin)
  75. Risk of acute myocardial infarction and low-dose combined oral contraceptives [letter]
  76. Risk of thromboembolic disease and oral contraceptive use. [Risque de maladie thrombo-embolique et contraceptifs oraux.]
  77. Risk of thrombosis with oral contraceptives -- si tacuisses (letter) [Thromboserisiko oraler Kontrazeptiva - si tacuisses.]
  78. Risk of venous thromboembolism and stroke associated with oral contraceptives. Role of congenital thrombophilias.
  79. The risks and benefits of contraceptive method regarding sexually transmitted infections.
  80. Risks of third-generation oral contraceptives [letter]
  81. Role of community based distribution in promoting spacing methods of family planning.
  82. The role of contraceptive supply and demand in Mexican fertility decline: evidence from a microdemographic study.
  83. The role of family planning and targeted credit programs in demographic change in Bangladesh.
  84. The role of family planning in preventing abortion.
  85. Role of oral contraceptives in the growth of a multilobular adenoma associated with a hepatocellular carcinoma in a young woman.
  86. The role of private providers in maternal and child health and family planning services in developing countries.
  87. The role of thromboxane A2 in increased whole blood platelet aggregation in oral contraceptive users.
  88. The role of triphasic levonorgestrel in oral contraception: a review of metabolic and hemostatic effects.
  89. Safe motherhood and child survival: the importance of family planning and the interdependence of services.
  90. Safety of combined oral contraceptive pills [letter]
  91. Safety of combined oral contraceptive pills [letter]
  92. Safety of combined oral contraceptive pills [letter]
  93. Safety of combined oral contraceptive pills. Authors' reply [letter]
  94. Safety of combined oral contraceptive pills. Authors' reply [letter]
  95. Safety of combined oral contraceptive pills. Authors' reply [letter]
  96. Safety of intrauterine contraceptive devices during MR imaging.
  97. Safety of modern oral contraceptives [letter]
  98. Safety of modern oral contraceptives [letter]
  99. Safety of modern oral contraceptives [letter]
  100. Safety of modern oral contraceptives [letter]
  101. Safety of modern oral contraceptives [letter]
  102. Schooling as contraception?
  103. Searching with Popline CD-ROM for family planning and reproduction health.
  104. Selective prescribing of third generation oral contraceptives (OCs)
  105. Serum immunoglobulin levels during contraceptive use of depot-medroxyprogesterone acetate in Indian women: a preliminary study.
  106. Service Delivery Expansion Support [SDES] baseline. Mexico family planning information.
  107. Service delivery guidelines for family planning programs.
  108. Service quality among women receiving MCH and family planning services.
  109. Sex education and contraception information (editorial) [Seksual- og praeventionsundervisning.]
  110. Sex preferences, family planning, and fertility: an Israeli subpopulation in transition.
  111. Sex, birth control and sexually transmitted diseases: teens voice their beliefs.
  112. Sexual and reproductive health (services, training, family planning, introduction to management of sexually transmitted diseases, research on the infertile couple). Reference text. 2nd ed. [Salud sexual y reproductiva (servicios, orientacion, planificacion familiar, introduccion al manejo de enfermedades de transmision sexual, investigacion de la pareja infertil). Texto de referencia. Segunda edicion.]
  113. Sexual attitudes and behaviours and contraceptive use of late female adolescents in Bangkok: a comparative study of students and factory workers.
  114. Sexual attitudes and contraceptive behavior revisited: can there be too much of a good thing?
  115. Sexual behavior of women seeking hormonal contraception and women seeking induced abortion. [Sexualni chovani zadatelek o hormonalni kontracepci a zadatelek o umele preruseni tehotenstvi.]
  116. Sexual behaviour, contraceptive practice and reproductive health among school adolescents in rural Transkei.
  117. Sexual reality. The gap between family planning services and clients' needs.
  118. Sexual values and family planning among charismatic and Pentecostal movements in Brazil.
  119. Sexually transmitted diseases, human immunodeficiency virus, and pregnancy prevention. Combined contraceptive practices among urban African-American early adolescents.
  120. A shift from family planning to reproductive health: new challenges.
  121. Short-term gonadotropin suppression with oral contraceptives benefits poor responders prior to controlled ovarian hyperstimulation.
  122. Shorter pill-free interval in combined oral contraceptives decreases follicular development.
  123. Should I take the pill? A guide to the combined oral contraceptive pill.
  124. Shy / silent users of contraceptives in Pakistan.
  125. The significance of long-term reversible contraception.
  126. Sindh. Follow-up of recommendations of the Workshops on Village Based Family Planning Workers Quality Improvement.
  127. A situation analysis of family planning service delivery at MHCs and BHSs in Maguindanao.
  128. Situation analysis of family planning service delivery points in Burkina Faso. Technical report. [Analyse situationnelle des points de prestation de services de PF du Burkina Faso. Rapport technique.]
  129. Situation analysis of family planning services in the Koulikoro and Sikasso regions, Mali. [Analyse situationnelle des services de planification familiale dans les regions de Koulikoro et Sikasso, Mali.]
  130. A situation analysis of the maternal and child health / family planning (MCH / FP) program in Botswana.
  131. Situation report: sexually transmitted disease / family planning program in Haiti.
  132. Smoking and cycle control among oral contraceptive users.
  133. The social costs of inadequate contraception.
  134. Social marketing: key to forging a public-private sector partnership for family planning in Guinea.
  135. Sociocultural milieu, women's status and family planning.
  136. Sociocultural variables in family planning programmes [letter]
  137. Some factors affecting the performance of hospital-based family planning clinics in eight district hospitals in the province of Ilocos Sur: a diagnostic study to increase the contraceptive prevalence rate (CPR)
  138. Some factors associated with the use of modern family planning methods in Tanzania: a case study of eight regions.
  139. Some observations on marriage, contraception and fertility in Bangladesh.
  140. Some priorities in maximizing access to and quality of contraceptive services.
  141. Some thoughts on clinical family planning studies (editorial)
  142. Son factor in family planning acceptance.
  143. Spatial variation in contraceptive method use in Bangladesh.
  144. Sperm transport and survival post-application of a new spermicide contraceptive.
  145. Spider naevi after discontinuation of oral contraceptives. [Spider naevi nach Absetzen oraler Kontrazeptiva.]
  146. Spousal communication and family planning decision-making in Nigeria.
  147. States continue to expand eligibility for family planning services under Medicaid.
  148. Statutory coherence and policy implementation: the case of family planning.
  149. STD risk assessment strategies for family planning clinics.
  150. Strategic directions for the Bangladesh National Family Planning Program, 1995-2005.
  151. Strategic policy development activities to achieve key conditions to phase-out AID assistance to the Indonesian Family Planning and Population Program. Draft.
  152. A strategy to increase private commercial sector involvement in the Philippines family planning program: situation analysis.
  153. Strengthening front-line supervision to improve performance of family planning field workers in Bangladesh.
  154. Stroke in users of low-dose oral contraceptives [letter]
  155. Stroke in users of low-dose oral contraceptives.
  156. Stroke in users of low-dose oral contraceptives. The authors reply [letter]
  157. A study of knowledge and attitudes towards contraception among health care staff in Kelantan (Malaysia)
  158. A study of non-users of family planning in Vietnam (summary / draft)
  159. A study of the lactational amenorrhoea method of family planning in New Zealand women.
  160. Subdermal contraceptive implant (Norplant) continuation rates among adolescents and adults in a family planning clinic.
  161. Subdermal implants -- still a viable longterm contraceptive option?
  162. Substance use in an inner-city family planning population.
  163. Summary proceedings: Invitational Meeting of Experts on Opportunities for Commerical Sector Involvement in Developing Country Family Planning Services, Friday, October 11, 1996, George Washington Room, Third Floor, Key Bridge Marriott Hotel, Arlington, Virginia.
  164. A survey of pre-pregnancy nutritional knowledge in family planning clinics.
  165. A survey of the quality and acceptability of immediate postpartum family planning advice in a hospital setting.
  166. Sustainability of family planning and health projects.
  167. Sustainable community-based family planning programmes.
  168. Tailoring family planning services to the special needs of adolescents: new adolescent approach protocols.
  169. Taking family planning services to hard-to-reach populations.
  170. A tale of two sexually transmitted diseases. Prevalences and predictors of chlamydia and gonorrhea in women attending Colorado family planning clinics.
  171. Technical report: fluoroscopically controlled retrieval of intra-uterine contraceptive devices.
  172. Teen sex, AIDS, and contraception: part three [editorial]
  173. Teen sex, AIDS, and contraception: part two [editorial]
  174. Teenagers' knowledge of emergency contraception: questionnaire survey in south east Scotland.
  175. Testosterone injections suppress sperm production, providing effective level of contraceptive protection.
  176. Thai royalty honours four for family planning.
  177. In their own words: a qualitative study of family planning in Jordan.
  178. A theoretical study on the quality of family planning service in China.
  179. Third generation oral contraceptives containing desogestrel and gestodene and the risk of thrombosis [editorial]
  180. Third-generation oral contraceptives and low free protein S as a risk for venous thrombosis [letter]
  181. Three aspects of the lactational amenorrhea method: contraceptive efficacy, women's comprehension of the method, and policy implications.
  182. A three-year clinical investigation into efficacy, cycle control and tolerability of a new low-dose monophasic oral contraceptive containing gestodene.
  183. Thromboembolic disease developing during oral contraceptive therapy in young females with antiphospholipid antibodies.
  184. Thromboembolism in primary pulmonary hypertension. No clear increased risk from oral contraceptives [editorial]
  185. Thrombosis caused by oral contraceptives: underreporting to the adverse effects registry. [Trombos av p-piller. Betydande underrapportering till biverkningsregistret.]
  186. Through the patient's eyes: strategies toward more successful contraception.
  187. The timing of family building and contraceptive sterilization. [Calendrier de constitution de la famille et recours a la sterilisation.]
  188. Title X at 25. Balancing national family planning needs with state flexibility.
  189. Towards regional equality in family planning: teenage pregnancies and abortions in Finland from 1976 to 1993.
  190. Towards third generation oral contraceptives.
  191. Traditional family planning: a myth or reality?
  192. Training experience in domiciliary injectable contraceptive services in the national family planning programme.
  193. Training of opinion leaders in family planning in India: does it serve any purpose?
  194. Training. Contraceptive technology update.
  195. Transient global amnesia in a young woman on prolonged treatment with oral contraceptive drugs [letter]
  196. Trends in abortion, contraception and fertility in three Latin American countries.
  197. Trends in adolescent fertility and contraceptive use in the developing world.
  198. Trends in contraception in the coming years [editorial]

     

  199. Trends in demographic, family planning, and health indicators in Indonesia, 1961-1994.
  200. The trends of contraceptives of people in Shanghai since early 1980s.
  201. A triphasic oral contraceptive pill, CTR-05: clinical efficacy and safety.
  202. U.S.-based international population and family planning organizations: a European perspective.
  203. Ultrasonographic monitoring of ovarian follicles in women using norethisterone for contraception.
  204. Understanding how family planning programs work: findings from five years of evaluation research.
  205. Unexpected sequelae of contraception.
  206. UNFPA and NCPEP sign new project to strengthen the population and family planning programme -- project VIE/96/PO1, "Projection and Family Planning Benefits and Savings: a Multi-Sectoral Analysis".
  207. The unmet family planning needs of breastfeeding women: lessons from Nigeria and Senegal.
  208. Unmet need for family planning in Uttar Pradesh.
  209. Unplanned pregnancy: is contraceptive failure predictable?
  210. Unsafe abortion and family planning in Togo. [Avortement a risques et planification familiale au Togo.]
  211. Unsafe abortion and post abortion family planning in Africa: the case of Lesotho.
  212. Unsatisfied demand for family planning services in a peri-urban community in Guatemala City. Draft final report.
  213. Urban men and their participation in family planning.
  214. Urban men and their participation in modern contraception: an exploratory study.
  215. Urea kinetics in healthy young women: minimal effect of stage of menstrual cycle, contraceptive pill and protein intake.
  216. USA aborts international family planning [letter]
  217. USA aborts international family planning.
  218. Use of computed tomography guidance and mammographic hook wires to remoke displaced, embedded contraceptive rods.
  219. Use of contraception by women seeking termination of pregnancy.
  220. Use of contraceptive methods during breast feeding. [Utilizacion de metodos anticonceptivos durante el periodo de lactancia.]
  221. Use of Demographic and Health Surveys data for family planning programme evaluation and health assessment.
  222. Use of depot medroxyprogesterone acetate contraception in adolescents.
  223. The use of nomegestrol acetate subdermal contraceptive implant, Uniplant, during lactation.
  224. Use of the oral contraceptive pill on treks and expeditions.
  225. Users of traditional methods of contraception in Bangladesh: 1981-91.
  226. Using an Ovarian Monitor as an Adjunct to Natural Family Planning [letter]
  227. In utero medroxyprogesterone exposure after contraceptive failure.
  228. Utilization of intrauterine contraceptive devices by patients of the Planned Parenthood Federation of America.
  229. Vatican snubs UNICEF, citing concerns over family planning.
  230. Venous thromboembolism and desogestrel- or gestodene-containing combination oral contraceptives: what are the facts?
  231. Volunteers in the Indonesian family planning program.
  232. Weighed in the balances -- and found beneficial. Assurance on safety of contraceptive pill.
  233. What are the particular aspects of counseling male family planning clients? Case from Kenya.
  234. What do family planning providers do before prescribing combined oral contraceptives?
  235. What do we really know about the impact of price changes on contraceptive use?
  236. What has hormonal contraception changed for women? [Qu'est-ce que la contraception hormonale a change pour la femme?]
  237. What proportion of births are the result of contraceptive failure in Bangladesh?
  238. What prospects for hormonal contraceptives for men?
  239. What women don't know about contraception.
  240. Whither methods for men? Emerging gender issues in contraception.
  241. Why pregnant adolescents say they did not use contraceptives prior to conception.
  242. Why young women in Dublin choose family planning centres for their contraceptive needs.
  243. Withdrawal popular in some cultures. Contraceptive update.
  244. Women of reproductive age are unfamiliar with many of the health effects of birth control pills, particularly its benefits. Although most consider "the pill" to be generally safe, many cite concerns about potential health risks. News release.
  245. Women's autonomy and gender roles in Egyptian families: implications for family planning and reproductive health.
  246. Women's knowledge and awareness of emergency contraception.
  247. Women's knowledge and preference about emergency contraception: a survey from a rural general practice.
  248. Women's perspective in the use of family planning spacing methods.
  249. Women's position and family planning in Egypt.
  250. Women's work, autonomy, and birth control: evidence from two South Indian villages.
  251. Women's work, autonomy, and birth control: evidence from two south Indian villages.
  252. Women, migration and current urban dynamics in China: fertility and family planning.
  253. Workshop on long-term contraceptives.
  254. World Health Organization (WHO) eligibility criteria for contraceptive use. [Criterios de la OMS de elegibilidad para el uso de anticonceptivos.]
  255. World Health Organization (WHO) eligibility criteria for oral contraceptive use. Part 2. [Criterios de la OMS de elegibilidad para el uso de anticonceptivos(segunda parte)]
  256. Yirgalem Family Planning Project: a mid-term review.
  257. Zanzibar family planning situation analysis study.
  258. The Zanzibar family planning situation analysis study. Tanzania.
  259. The mass media and family planning in Kenya.
  260. Scare over oral contraceptives. Effect on women in a general practice in Devon [letter]
  261. The acceptability of a combined oestrogen / progestogen contraceptive vaginal ring.
  262. Assessing the impact of a family planning nurse training program in Egypt.
  263. Centchroman: a new non-steroidal oral contraceptive in human milk.
  264. Climacteric symptoms and control of the cycle in women aged 35 years or older taking an oral contraceptive with 0.150 micrograms desogestrel and 0.020 micrograms ethinylestradiol.
  265. Clinical trial with Nestorone subdermal contraceptive implants.
  266. Contraception and the risk of ectopic pregnancy: a meta-analysis.
  267. Contraceptive use and the risk of HIV infection in Nairobi, Kenya.
  268. Designer contraceptive pills.
  269. Determinants of cervical ectopia and of cervicitis: age, oral contraception, specific cervical infection, smoking, and douching.
  270. Developing a culturally appropriate family planning program for the Navrongo experiment.
  271. Effects of low-dose estrogen oral contraceptives on weight, body composition, and fat distribution in young women.
  272. The effects of steroidal contraceptives on the well-being and sexuality of women: a double-blind, placebo-controlled, two-centre study of combined and progestogen-only methods.
  273. A family planning intervention to reduce vertical transmission of HIV in Rwanda.
  274. Flawed research does not permit valid inferences about Cu-7 intrauterine contraceptive device [letter]
  275. From birth control to reproductive health. Social issues in reproductive health.
  276. Hospital referral for headache and oral contraceptive use: findings in a large cohort study.
  277. Influence of high doses of vitamin C on the bioavailability and the serum protein binding of levonorgestrel in women using a combination oral contraceptive.
  278. Initiation of contraception postpartum.
  279. Large increase in plasmatic 11-dehydro-TxB2 levels due to oral contraceptives.
  280. Levonorgestrel as a postcoital contraceptive.
  281. Oral contraceptives and low back pain. Attitudes among physicians, midwives and physiotherapists.
  282. A pilot program of contraceptive continuation in six school-based clinics.
  283. Pope John Paul II on abortion, contraception, and euthanasia.
  284. Quality of condom use as reported by female clients of a family planning clinic.
  285. Recent trends in incidence of and mortality from breast, ovarian and endometrial cancers in England and Wales and their relation to changing fertility and oral contraceptive use.
  286. Twelve years of clinical experience with an oral contraceptive containing 30 micrograms ethinyloestradiol and 150 micrograms desogestrel.
  287. Ultrasonographically guided intrauterine contraceptive device removal before chorionic villus sampling.
  288. Use of levonorgestrel implants versus oral contraceptives in adolescence: a case-control study.
  289. Using operations research to guide family planning program development and policy formulation in Sub-Saharan Africa.
  290. Barrier methods, natural family planning, and future directions.
  291. Hormonal contraceptives and the IUD.
  292. Shaping contraceptive technology.
  293. Fertility patterns and family planning acceptance among slum dwellers in Kanpur.
  294. Contraceptives: our choices, their choices.
  295. Contraceptives social marketing: Indonesian experience. Blue Circle project.
  296. A guide to methods of family planning program evaluation, 1965-1990, with selected bibliography.
  297. Postabortion women: factors influencing their family planning options.
  298. Quality management for family planning services: practical experience from Africa.
  299. Contraceptive use among high school students in Kenya.
  300. Contraceptive discontinuation in six developing countries: a cause-specific analysis.
  301. The social context of family planning in a south Indian village.
  302. Access, quality of care and medical barriers in family planning programs.
  303. When fertility seems too high for contraceptive prevalence: an analysis of Northeast Brazil.
  304. Why is oral contraceptive use in Vietnam so low?
  305. Differentials in contraceptive use and method choice in Vietnam.
  306. Decentralizing health and family planning services. [Décentralisation des services de santé et de planification familiale; La descentralización de los servicios de salud y planificación familiar.]
  307. Helping the news media cover family planning./Amener les medias a couvrir la planification familiale./Como avudar a los medios de difusion a informar sobre la planificacion familiar.
  308. Action against contraceptive implant threatened.
  309. Combined oral contraceptives and thromboembolism [letter]
  310. Contraceptive services for teenagers: do we need family planning clinics?
  311. Controversy over new data on oral contraceptives. GPs were swamped by calls [letter]
  312. Controversy over new data on oral contraceptives. Perception of risk is affected by presentation [letter]
  313. Controversy over new data on oral contraceptives. Risk of delay was small [letter]
  314. Controversy rages over new contraceptive data.
  315. Data from transnational study of oral contraceptives have been misused [letter]
  316. Emergency contraception. Time to loosen medical controls over its availability.
  317. Pregnant teenagers and contraception. Contraceptive failure may be a major factor in teenage pregnancy [letter]
  318. Pregnant teenagers and contraception. The needs of older women are just as great [letter]
  319. Pregnant teenagers and contraception. Women know little about emergency contraception, and men know less [letter]
  320. Pregnant teenagers' knowledge and use of emergency contraception.
  321. Scare over oral contraceptives. Committee's action has compromised continuing studies [letter]
  322. Scare over oral contraceptives. Committee's action will undermine further research and development [letter]
  323. Scare over oral contraceptives. Doctors should take warning seriously [letter]
  324. Scare over oral contraceptives. Effect on behaviour of women attending a family planning clinic [letter]
  325. Scare over oral contraceptives. Effect on women in a general practice in south Wales [letter]
  326. Scare over oral contraceptives. If a woman has not had a thrombotic event in years of use she is unlikely to have one now [letter]
  327. Scare over oral contraceptives. Main public health issue is failure to use contraception [letter]
  328. Scare over oral contraceptives. New group will review evidence for effective care in family planning [letter]
  329. Scare over oral contraceptives. Risk is highest during first months of use [letter]
  330. Scare over oral contraceptives. Was Committee on Safety of Medicines' advice arrived at lawfully? [letter]
  331. Third generation oral contraceptive pills [editorial]
  332. Third generation oral contraceptives -- the controversy.
  333. Training in family planning encompasses several disciplines [letter]
  334. 1995 Survey of Obstetrician / Gynecologists on Contraception and Unplanned Pregnancy: Attitudes and Practices with Regard to Abortion. Chart Pack.
  335. 1995 training catalog. Management training for health and family planning professionals.
  336. 25 years family planning movement. [25 tahun gerakan keluarga berencana.]
  337. 30 years of change: the current perspective on cardiovascular risks and oral contraceptives.
  338. Abortion and contraceptive practice in central Asia.
  339. Abortion and family planning foes push sweeping measures in Congress. Reproductive freedom alert.
  340. About 40% of Indian women practice contraception; only one in four users rely on reversible methods.
  341. Absence of antisteroid antibodies in oral contraceptive users presenting with vascular events.
  342. Acceptance of spacing methods of contraception in municipal corporation of Delhi.
  343. Access to family planning services, service quality, and contraceptive use in northeast Brazil.
  344. Access to family planning workers facilitates choice of modern over traditional methods in Bangladesh.
  345. ACOG issues report on hormonal contraception. [Excerpts]
  346. Acrosin inhibitor, 4'-acetamidophenyl 4-guanidinobenzoate, an experimental vaginal contraceptive with anti-HIV activity.
  347. Adolescent contraceptive use and its determinants in Bangladesh: evidence from Bangladesh Fertility Survey 1989.
  348. Adolescent contraceptive use: the facts.
  349. Adolescent girls' attitudes toward contraceptive subdermal implants.
  350. Adolescent knowledge and use of injectable contraceptives in developing countries.
  351. Adolescent sex, contraception, and childbearing: a review of recent research.
  352. Adolescents and young people facing contraception, pregnancy and abortion. [Los adolescentes y los jovenes frente a la anticoncepcion, el embarazo y el aborto.]
  353. Advances in oral hormonal contraception.
  354. Advertising emergency contraception [editorial]
  355. AIDS and STDs: priorities for family planning programs.
  356. Alcohol use and contraception in first sexual experiences.
  357. Ambulatory blood pressure in mild hypertensive women taking oral contraceptives: a case-control study.
  358. Analysis of factors affecting women's utilisation of family planning services in Zambia.
  359. Androgenic effects of oral contraceptives: implications for patient compliance.
  360. Androgens and women's health: pharmacodynamic considerations for contraception.
  361. Annual report: Family Planning Logistics, 1994-95.
  362. Antibiotics and contraceptives [letter]
  363. Antithrombin III deficiency, deep venous thrombosis, and oral contraceptive use.
  364. Application of the rank sum ratio (RSR) method in comprehensive evaluation of family planning programs.
  365. Are low-dose oral contraceptives safer and better? [letter]
  366. Assessing family planning service-delivery practices: the case of private physicians in Jamaica.
  367. Assessing the acceptability of Norplant contraceptive in four patient populations.
  368. Assessing the impact of the quality of family planning services on fulfillment of reproductive intentions in Peru.
  369. Assessment of contraceptive choice in HIV seropositive women [letter]
  370. Assessment of post-abortion family planning services in Vietnam.
  371. An assessment of the potential of health attendants for family planning and reproductive health expansion in Tanzania. Draft.
  372. Association for Population/Family Planning Libraries and Information Centers--International (APLIC-I) union list of serials.
  373. Audit of an emergency contraception service.

     

  374. AVSC addresses client perspectives in family planning.
  375. Awareness of different contraceptive methods among current family planning acceptors in urban Pondicherry.
  376. The Bangladesh Family Planning and Health Services Project (388-0071): evaluation report.
  377. Bangladesh's family planning success story: a gender perspective.
  378. Bangladesh. Family planning enhances women's status in Bangladesh.
  379. Barrier methods of contraception.
  380. Barriers to condom use among women attending Planned Parenthood clinics.
  381. Beyond the freedom to choose: Medicaid, managed care, and family planning.
  382. Binary outcomes and endogenous explanatory variables: tests and solutions with an application to the demand for contraceptive use in Tunisia.
  383. Biological patterns of adolescents using combined estrogen-progestogen oral contraceptives] [Statut biologique des jeunes filles sous oestroprogestatifs (OP)]
  384. Birth control counseling for HIV seropositive pregnant women.
  385. Birth control in Peru]
  386. The birth control movement before Roe v. Wade.
  387. Birth control, population control, and family planning: an overview.
  388. A birth-control vaccine. Scientists seek ways to trick the immune system into preventing pregnancies.
  389. Bolivia survey: rhythm accounts for one-half of all contraceptive use.
  390. Bone mass and long-term monophasic oral contraceptive treatment in young women.
  391. Brazilian physician donates time to teach birth control. [Script]
  392. Breast feeding: which contraceptive method? [Allaitement maternel: quelle contraception?]
  393. Breast-cancer risk and oral contraceptive use in Slovenian women aged 25 to 54.
  394. California may become first state to mandate insurance coverage for contraception.
  395. Cambodian refugees' family planning knowledge and use.
  396. Cardiovascular risk profiles of oral contraceptive users and nonusers: a population-based study.
  397. The case for business action on family planning and AIDS prevention in Ghana.
  398. The case for rapid assessment surveys for family planning program evaluation.
  399. Case studies of collaboration between family planning agencies and managed care organizations.
  400. The causes of unmet need for contraception and the social content of services.
  401. Cebu study shows relationship between family planning, work.
  402. Centre shares its success in family planning work with the NGOs in the SAARC region.
  403. Cervical cytology associated with levonorgestrel contraception.
  404. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity.
  405. A changing pattern in the association of oral contraceptives and the different groups of congenital limb deficiencies.
  406. Characteristics and experiences of American women electing for early removal of contraceptive implants.
  407. Characteristics of injectable contraceptive users in a low-income population in Texas.
  408. China's women leaders promote quality and equity in family planning.
  409. China: women benefit from the family planning programme.
  410. Choice and monitoring of a contraceptive method in the absence of risk factors. [Choix et surveillance d'une contraception en l'absence de facteur de risque.]
  411. Choice of contraceptive method for birth control and attitudes toward abortion in Swedish women ages 23-29.
  412. Choice of contraceptive method related to health locus of control in Brazilian women.
  413. Choice of family planning service provider in Egypt.
  414. Classification and comparison of oral contraceptives containing new generation progestogens.
  415. Classification and comparison of oral contraceptives containing new generation progestogens.
  416. Classification and comparison of oral contraceptives containing new generation progestogens.
  417. Clinical study of a low-dose contraceptive -- Femodene. [Klinichno prouchvane na niskodoziran kontraseptiv -- Femoden.]
  418. A clinical trial of Exluton, a progestogen only contraceptive pill containing 0.5mg lynestrenol amongst lactating Zimbabwean women.
  419. Clinical trials of a new contraceptive device -- medicated r-IUD. Collaborative Study Group of IUD.
  420. Coercion and long-term contraceptives.
  421. Combined estrogen-progestin oral contraception. [Pilules estroprogestatives.]
  422. The combined oral contraceptive. Risks and adverse effects in perspective.
  423. Combined oral contraceptives and risk of cervical carcinoma in situ.
  424. Combined oral contraceptives: do we know all of their effects?
  425. A combined phasic oral contraceptive containing ethinylestradiol and desogestrel. [Kombifasisk p-pillepraeparation bestaende af ethinylestradiol og desogestrel.]
  426. Combined use of condoms with other contraceptive methods among inner-city Baltimore women.
  427. Communication strategies to maximize access and improve the quality of family planning and reproductive health care services.
  428. Communication strategy for health and family planning in Uttar Pradesh.
  429. Community-based distribution of contraceptives: a guide for programme managers.
  430. Community-based services for family planning: the role of the medical profession.
  431. A comparative evaluation of oral contraceptive use and associated compliance issues in a rural population.
  432. A comparative study of one-year weight gain among users of medroxyprogesterone acetate, levonorgestrel implants, and oral contraceptives.
  433. Comparative study on intermittent versus continuous use of a contraceptive pill administered by vaginal route.
  434. A comparative study on the return to ovulation following chronic use of once-a-month injectable contraceptives.
  435. Compliance and oral contraceptives: a review.
  436. Complications of intrauterine contraceptive devices (IUDs) [Complication des dispositifs intra-uterins.]
  437. Comprehensive guidebook to the Bangladesh family planning-MCH program.
  438. The concept of coordination and integration in the Indonesian family planning program.
  439. Condom distribution: contraception and prevention. [La diffusion des preservatifs: contraception et prevention.]
  440. Condom use among Norplant users and oral contraceptive users.
  441. Condoms, family planning and living with HIV in Zimbabwe.
  442. Consensus statement on emergency contraception.
  443. Consensus statement: lactational amenorrhea method for family planning.
  444. A contextual analysis of the relationship between education and contraception across twenty seven developing countries.
  445. Contraception among adolescents in Bangladesh.
  446. Contraception and abortion in the countries of Eastern Europe. [Contraception et avortement dans les pays d'Europe de l'Est.]
  447. Contraception and adolescents: highlights from the NASPAG conference.
  448. Contraception and uterine pathology. [Contraception et pathologie gynecologique uterine.]
  449. Contraception for the woman with fibroids. Question and answer.
  450. Contraception in the adolescent patient.
  451. Contraception in the later reproductive years: a valid aspect of preventive health care.
  452. Contraception in women with a contraindication for combined estrogen-progestin contraceptives. [Contraceptions chez des femmes ayant une contre-indication aux oestroprogestatifs.]
  453. Contraception prevalence under rural poverty: the case of the rural areas of Kondoa District, Tanzania.
  454. Contraception update: implantable and injectable methods.
  455. Contraception with injectable long-acting preparation Depo-Provera. [Kontratseptsiia inektsionnym prolongirovannym preparatom "Depo-Provera".]
  456. Contraception.
  457. Contraception.
  458. Contraception: a clinical review for the internist.
  459. Contraception: awareness and practice amongst Nigerian tertiary school girls.
  460. Contraceptive and condom use adoption and maintenance: a stage paradigm approach.
  461. Contraceptive and condom use adoption and maintenance: a stage paradigm approach.
  462. Contraceptive and Reproductive Evaluation Branch, NICHD: report to the NACHHD Council.
  463. Contraceptive behavior in Ghana: a two-sex model.
  464. Contraceptive care in a general practice.
  465. Contraceptive choice in Indonesia: 1987 and 1991.
  466. Contraceptive choice in Vigevano, Italy, 1983-1993.
  467. Contraceptive choice, fertility, and public policy in Zimbabwe.
  468. Contraceptive choices: the adolescent years.
  469. Contraceptive Development. From men to men: creating a male hormonal contraceptive. [Desarrollo de métodos anticonceptivos. De hombre a hombre: creación de un anticonceptivo hormonal masculino.]
  470. Contraceptive effectiveness with intrauterine devices in a general practice clinic.
  471. Contraceptive effects of antiprogestogens.
  472. Contraceptive efficacy [editorial]
  473. Contraceptive efficacy and safety of a monophasic oral contraceptive containing 150 mcg desogestrel and 30 mcg ethinyl estradiol: United States clinical experience using a "Sunday start" approach.
  474. Contraceptive efficacy. [A eficacia contraceptiva.]
  475. Contraceptive goals and evaluation of newly-married couples in Shanghai, China.
  476. The contraceptive implant and the injectable: a comparison of costs.
  477. Contraceptive implant use among inner city teens.
  478. Contraceptive implants: friend or foe?
  479. Contraceptive method choice among newly married couples and influential factors in Shanghai municipality.
  480. Contraceptive method-mix and family planning program in Vietnam.
  481. Contraceptive methods and the risk of Chlamydia trachomatis infection in young women.
  482. Contraceptive methods use -- the gender difference.
  483. Contraceptive needs of chronic psychiatric patients.
  484. Contraceptive policy and ethics: illustrations from American history.
  485. Contraceptive practices in France. [Les pratiques contraceptives en France.]
  486. Contraceptive practices of women attending for termination of pregnancy -- a study from South Australia.
  487. Contraceptive Prevalence Survey, Jamaica, 1993. Volume IV: Sexual behaviour and contraceptive use among young adults.
  488. Contraceptive price changes: the impact on sales in Bangladesh.
  489. Contraceptive requirements and logistics management needs in Bangladesh.
  490. Contraceptive requirements and logistics management needs in Brazil.
  491. Contraceptive research and development: progress toward a woman-centered agenda.
  492. Contraceptive safety -- listening to the views of the users.
  493. Contraceptive social marketing. The value of choice.
  494. Contraceptive sponge discontinued.
  495. Contraceptive technology. Injectable contraceptives. [Technologie contraceptive. Les contraceptifs injectables.]
  496. Contraceptive use and fertility in India: a case study of Gujarat.
  497. Contraceptive use and reproductive history in women with cervical human papillomavirus infection.
  498. Contraceptive use and unmet need: a micro-economic model and its application to Egypt.
  499. Contraceptive use differentials in two slum populations of Greater Bombay.
  500. Contraceptive use dynamics in Egypt.

To view other lists of the current category of articles, please visit "Category Lists Homepage"


Web PubHealth.info

© Copyrights PubHealth.info®, an information portal on public health. All rights reserved.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.